Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kuti, Joseph L.
360  Ergebnisse:
Personensuche X
?
1

A New Dosing Frontier: Retrospective Assessment of Effluent..:

Lakshmipathy, Damini ; Ye, Xiaoyi ; Kuti, Joseph L...
Critical Care Explorations.  6 (2024)  4 - p. e1065 , 2024
Link: https://doi.org/10.1097/..
 
?
2

Response to comment on "International consensus recommendat..:

Hong, Lisa T. ; Downes, Kevin J. ; FakhriRavari, Alireza...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  44 (2024)  2 - p. 208-209 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors..:

Fratoni, Andrew J ; Gethers, Matthew L ; Nicolau, David P.
Clinical Infectious Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
4

Imipenem/relebactam pharmacokinetics in critically ill pati..:

Fratoni, Andrew J ; Kois, Abigail K ; Gluck, Jason A..
Journal of Antimicrobial Chemotherapy.  79 (2024)  5 - p. 1118-1125 , 2024
Link: https://doi.org/10.1093/..
 
?
5

Exebacase in Addition to Standard-of-Care Antibiotics for S..:

Fowler Jr, Vance G ; Das, Anita F ; Lipka-Diamond, Joy...
Clinical Infectious Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
6

Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal..:

Berry, Angela V. ; Conelius, Allison ; Gluck, Jason A...
European Journal of Drug Metabolism and Pharmacokinetics.  48 (2023)  4 - p. 437-441 , 2023
Link: https://doi.org/10.1007/..
 
?
7

1174. Impact of an Electronic Antibiotic Time-out Best Prac..:

Ackley, Tyler ; Kuti, Joseph L ; Bilinskaya, Anastasia..
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
8

Antimicrobial Stewardship in the Intensive Care Unit:

, In: Antimicrobial Stewardship in Non-Traditional Settings,
Chen, Iris H. ; Nicolau, David P. ; Kuti, Joseph L. - p. 161-183 , 2023
Link: https://doi.org/10.1007/..
 
?
9

International consensus recommendations for the use of prol..:

Hong, Lisa T. ; Downes, Kevin J. ; FakhriRavari, Alireza...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  43 (2023)  8 - p. 736-739 , 2023
Link: https://doi.org/10.1002/..
 
?
10

972. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics ..:

Fratoni, Andrew J ; Kois, Abigail ; Gluck, Jason A..
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
11

1227. Analysis of Prescriber Interaction with an Electronic..:

Ackley, Tyler ; Bilinskaya, Anastasia ; Kuti, Joseph L..
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
12

Physical compatibility of sulbactam/durlobactam with select..:

Ruiz, Victor H ; Shen, Yuwei ; Abouelhassan, Yasmeen...
American Journal of Health-System Pharmacy.  81 (2023)  1 - p. e21-e29 , 2023
Link: https://doi.org/10.1093/..
 
?
13

2526. Ex Vivo Assessment of Sulbactam-Durlobactam (SUL-DUR)..:

Abouelhassan, Yasmeen ; Shen, Yuwei ; Chen, April...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
14

Bronchopulmonary disposition of IV cefepime/taniborbactam (..:

Asempa, Tomefa E ; Kuti, Joseph L ; Nascimento, Jeffrey C...
Journal of Antimicrobial Chemotherapy.  78 (2023)  3 - p. 703-709 , 2023
Link: https://doi.org/10.1093/..
 
?
15

International consensus recommendations for the use of prol..:

Hong, Lisa T. ; Downes, Kevin J. ; FakhriRavari, Alireza...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  43 (2023)  8 - p. 740-777 , 2023
Link: https://doi.org/10.1002/..
 
1-15